Key statistics
On Friday, Camurus AB (7CA:FRA) closed at 61.40, -2.38% below its 52-week high of 62.90, set on Jun 04, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 61.65 |
---|---|
High | 61.90 |
Low | 61.40 |
Bid | 61.95 |
Offer | 62.00 |
Previous close | 62.20 |
Average volume | 351.00 |
---|---|
Shares outstanding | 59.66m |
Free float | 34.89m |
P/E (TTM) | 75.77 |
Market cap | 41.40bn SEK |
EPS (TTM) | 9.16 SEK |
Data delayed at least 15 minutes, as of Jul 18 2025 13:34 BST.
More ▼
Press releases
- Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
- Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
- Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients
- Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients
- Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
- Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins
- CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
- CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU
More ▼